Economic evaluation supports prophylactic naldemedine for opioid-induced constipation in cancer palliative care. Although opioids remain indispensable for pain relief in patients with advanced cancer, their use frequently results in OIC, which can substantially reduce quality of life and, in some cases, compromise the continuation of optimal pain management.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Although opioids remain indispensable for pain relief in patients with advanced cancer, their use frequently results in OIC, which can substantially reduce quality of life and, in some cases, compromise the continuation of optimal pain management. Naldemedine, a peripherally acting μ-opioid receptor antagonist, is used to treat OIC by preserving physiological bowel motility without interfering with central analgesia.
- Ponto de atenção: economic.
- Ponto de atenção: evaluation.
- Ponto de atenção: supports.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
